Evidence map›Paper›PMID 38542359›Full record

ReviewInternational journal of molecular sciences2024

Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline.

Vi Nguyen, Elaine G Taine, Dehao Meng, Taixing Cui, Wenbin Tan

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
16.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Vi NguyenDepartment of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-0688-0286
Elaine G TaineTritaliMed, Inc., Columbia, SC 29223, USA.
Dehao MengApplied Physics Program, California State University San Marcos, San Marcos, CA 92096, USA.
Taixing CuiDalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, MO 65211, USA.
Wenbin TanDepartment of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-2334-8988
University of South Carolina · USCalifornia State University, San Marcos · USUniversity of Missouri · US

Funding

Metabolic control of vascular smooth muscle cell plasticityR01HL160541 · NHLBI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI CUI, TAIXING · 2022 to 2025
$2.0M
Vascular Pathogenesis of Port Wine StainR01AR073172 · NIAMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TAN, WENBIN · 2018 to 2022
$1.5M
Generation and Validation of Disease Models for Port-Wine BirthmarksR21AR083066 · NIAMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI TAN, WENBIN · 2023 to 2024
$356k
Cyclin-dependent kinase (CDK)19-mediated vein graft intimal hyperplasiaR03TR004450 · NCATS · UNIVERSITY OF MISSOURI-COLUMBIA · PI CUI, TAIXING · 2023 to 2023
$157k
NCATS NIH HHS R03 TR004450NHLBI NIH HHS R01 HL160541NIAMS NIH HHS R01 AR073172NIAMS NIH HHS R21 AR083066NIH HHS R01AR073172, 1R21AR083066, R01HL160541, R03TR004450
6 · The paper itself

Abstract

Trigonelline (TRG) is a natural polar hydrophilic alkaloid that is found in many plants such as green coffee beans and fenugreek seeds. TRG potentially acts on multiple molecular targets, including nuclear factor erythroid 2-related factor 2 (Nrf2), peroxisome proliferator-activated receptor γ, glycogen synthase kinase, tyrosinase, nerve growth factor, estrogen receptor, amyloid-β peptide, and several neurotransmitter receptors. In this review, we systematically summarize the pharmacological activities, medicinal properties, and mechanistic actions of TRG as a potential therapeutic agent. Mechanistically, TRG can facilitate the maintenance and restoration of the metabolic homeostasis of glucose and lipids. It can counteract inflammatory constituents at multiple levels by hampering pro-inflammatory factor release, alleviating inflammatory propagation, and attenuating tissue injury. It concurrently modulates oxidative stress by the blockage of the detrimental Nrf2 pathway when autophagy is impaired. Therefore, it exerts diverse therapeutic effects on a variety of pathological conditions associated with chronic metabolic diseases and age-related disorders. It shows multidimensional effects, including neuroprotection from neurodegenerative disorders and diabetic peripheral neuropathy, neuromodulation, mitigation of cardiovascular disorders, skin diseases, diabetic mellitus, liver and kidney injuries, and anti-pathogen and anti-tumor activities. Further validations are required to define its specific targeting molecules, dissect the underlying mechanistic networks, and corroborate its efficacy in clinical trials.

Indexed as

AlkaloidsDiabetes MellitusHumansNF-E2-Related Factor 2Oxidative StressAlkaloidsNF-E2-Related Factor 2trigonellinechronic metabolic diseasesinflammationmetabolic homeostasisneuromodulationoxidationtrigonelline

Identifiers

PMID38542359
PMCPMC10970276
OpenAlexW4392926392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.